PRESS RELEASES
Currently Viewing:
Feb 24, 2010
Stem Cell Therapeutics Corp. Announces Presentations at the American Stroke Association's International Stroke Conference 2010
Feb 16, 2010
Stem Cell Therapeutics Corp. Provides Update on Modified REGENESIS Phase IIb Stroke Trial
Feb 09, 2010
Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trial
Jan 28, 2010
Stem Cell Therapeutics Corp. Receives 'No Objection Letter' From Health Canada for the Phase IIa Clinical Trial in Traumatic Brain Injury Patients
Jan 11, 2010
Stem Cell Therapeutics Corp. Announces Second Positive Review by Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trial and Provides Corporate Update
Dec 11, 2009
Stem Cell Therapeutics Corp. Adds Another U.S. Patent to Its Intellectual Property Portfolio
Dec 10, 2009
Stem Cell Therapeutics Corp. Announces Additional U.S. Patent
Nov 25, 2009
Stem Cell Therapeutics Corp. Announces Regenerative Medicine Panel Discussion led by Dr. Allen Davidoff
Nov 23, 2009
Stem Cell Therapeutics Corp. Announces Third Quarter Financial Results
Nov 20, 2009
Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb Stroke Trial
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade: 0.275
Change: 0.00%
Volume: 87425
Date: 3/9/2010
Time: 3:59pm

Note: Quotes are delayed. For informational purposes only.

LETTER TO SHAREHOLDERS
+ 2008 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved